1Starr R,Willson TA,Viney EM,et al.A family of cytokine-inducible inhibitors of signaling[].Nature.1997
2Endo TA,Masuhara M,Yokouchi M,et al.A new protein containing an SH2 domain that inhibits JAK kinase[].Nature.1997
3Matsumoto A,Masuhara M,Mitsui K,et al.CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation[].Blood.1997
4Narazaki M,Fujimo M,Matsumoto A,et al.Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling[].Proceedings of the National Academy of Sciences of the United States of America.1998
5Yasukawa H,Misawa H,Sakamoto H,et al.The JAK-binding protein JAB inhibits janus tyrosine kinase activity through binding in the activation loop[].EMBO Journal.1999
6Okabe S,Tauchi T,Morita H,et al.Thrombopoietin induces an SH2containing protein, CIS1, which binds to Mpl: involvement of the ubiquitin proteosome pathway[].Experimental Hematology.1999
7Marine JC,Topham DJ,McKay C,et al.SOCS-1 deficiency cause a lymphocyte-dependent perinatal lethality[].Cell.1999
8Alexander WS,Starr R,Fenner JE,et al.SOCS 1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine[].Cell.1999
9Marine JC,McKay C,Wang D,et al.SOCS-3 is essential in the regulation of fetal liver erythropoiesis[].Cell.1999
10Starr R,Metcalf D,Elefanty AG,et al.Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1[].Proceedings of the National Academy of Sciences of the United States of America.1998
2Nakao S. Immune mechanism of aplastic anemia[J]. Intern J Hematol, 1997,66(2) : 127-134.
3Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin,cyclosporine, and granulocyte colony-stimulating fader for severe aplastic anemia:an update of the GITMO/EBMT study on 100 patients [J]. Blood ,2000,95 (6) : 1931-1934.
4Frickhofen N, Rosenfeld S. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine[J]. Semin Hematol,2000,37(1) :56-68.
6Spsikkelman A, de wolf JT, Vellenga E. The application of hematopoietic growth factors in drug-induced a granulocytosis: a review of 70 cases [J] .leukemia 1994, 8 (12): 2031.
7Peters BG, Adkins Dr, Harison Br, et al. Antifungal effects of yeast-derived rhGM-CSF in patients receiving high-dose chemotherapy given with or withuot autologous stem cell transplantation: a retrospective analysis [J] . Bone marrow transplant 1996, 18 (1) 93.
8Alvarado Ibarra ML, Borbolla Eseoboza JR, Lopez Hemandez MA, et al. Neutrophil recovery time and adverse side effeets in aeute leukemia patients treated with intensive chemotherapy and coneomitant G or GM-CSF [J] . Rev Invest Clin, 1999,51 (2):77.
9Cesaro S, Marson P, Gazzola MV, et al. The use of cytokine-stimulated healated healthy donores in allogeneie stem call transplantation [J] . Haematologiea, 2002, 87 (8 supp): 35.
10Mori T, Sato N, Watanabe R, et al. Erythema exudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor [J] . Bone Marrow Transplant, 2000,26 (2): 239.
